This title appears in the Scientific Report :
2016
Please use the identifier:
http://hdl.handle.net/2128/10957 in citations.
Please use the identifier: http://dx.doi.org/10.1371/journal.pone.0153035 in citations.
Optimization of the All-D Peptide D3 for Aβ Oligomer Elimination
Optimization of the All-D Peptide D3 for Aβ Oligomer Elimination
The aggregation of amyloid-β (Aβ) is postulated to be the crucial event in Alzheimer’s disease (AD). In particular, small neurotoxic Aβ oligomers are considered to be responsible for the development and progression of AD. Therefore, elimination of thesis oligomers represents a potential causal thera...
Saved in:
Personal Name(s): | Klein, Antonia Nicole |
---|---|
Ziehm, Tamar / Tusche, Markus / Buitenhuis, Johan / Bartnik, Dirk / Boeddrich, Annett / Wiglenda, Thomas / Wanker, Erich / Funke, Susanne Aileen / Brener, Oleksandr / Gremer, Lothar / Kutzsche, Janine / Willbold, Dieter (Corresponding author) | |
Contributing Institute: |
Weiche Materie; ICS-3 Strukturbiochemie; ICS-6 |
Published in: | PLoS one, 11 (2016) 4, S. e0153035 - |
Imprint: |
Lawrence, Kan.
PLoS
2016
|
DOI: |
10.1371/journal.pone.0153035 |
Document Type: |
Journal Article |
Research Program: |
Functional Macromolecules and Complexes Physical Basis of Diseases |
Link: |
OpenAccess OpenAccess |
Publikationsportal JuSER |
Please use the identifier: http://dx.doi.org/10.1371/journal.pone.0153035 in citations.
LEADER | 06911nam a2201045 a 4500 | ||
---|---|---|---|
001 | 809114 | ||
005 | 20220930130059.0 | ||
024 | 7 | |a 10.1371/journal.pone.0153035 |2 doi | |
024 | 7 | |a 2128/10957 |2 Handle | |
024 | 7 | |a WOS:000374565100009 |2 WOS | |
037 | |a FZJ-2016-02505 | ||
041 | |a English | ||
082 | |a 500 | ||
100 | 1 | |a Klein, Antonia Nicole |0 P:(DE-Juel1)145785 |b 0 | |
245 | |a Optimization of the All-D Peptide D3 for Aβ Oligomer Elimination | ||
260 | |a Lawrence, Kan. |c 2016 |b PLoS | ||
520 | |a The aggregation of amyloid-β (Aβ) is postulated to be the crucial event in Alzheimer’s disease (AD). In particular, small neurotoxic Aβ oligomers are considered to be responsible for the development and progression of AD. Therefore, elimination of thesis oligomers represents a potential causal therapy of AD. Starting from the well-characterized D-enantiomeric peptide D3, we identified D3 derivatives that bind monomeric Aβ. The underlying hypothesis is that ligands bind monomeric Aβ and stabilize these species within the various equilibria with Aβ assemblies, leading ultimately to the elimination of Aβ oligomers. One of the hereby identified D-peptides, DB3, and a head-to-tail tandem of DB3, DB3DB3, were studied in detail. Both peptides were found to: (i) inhibit the formation of Thioflavin T-positive fibrils; (ii) bind to Aβ monomers with micromolar affinities; (iii) eliminate Aβ oligomers; (iv) reduce Aβ-induced cytotoxicity; and (v) disassemble preformed Aβ aggregates. The beneficial effects of DB3 were improved by DB3DB3, which showed highly enhanced efficacy. Our approach yielded Aβ monomer-stabilizing ligands that can be investigated as a suitable therapeutic strategy against AD. | ||
588 | |a Dataset connected to CrossRef | ||
700 | 1 | |a Ziehm, Tamar |0 P:(DE-Juel1)162487 |b 1 |u fzj | |
700 | 1 | |a Tusche, Markus |0 P:(DE-Juel1)131709 |b 2 |u fzj | |
700 | 1 | |a Buitenhuis, Johan |0 P:(DE-Juel1)130577 |b 3 |u fzj | |
700 | 1 | |a Bartnik, Dirk |0 P:(DE-Juel1)131991 |b 4 | |
700 | 1 | |a Boeddrich, Annett |0 P:(DE-HGF)0 |b 5 | |
700 | 1 | |a Wiglenda, Thomas |0 P:(DE-HGF)0 |b 6 | |
700 | 1 | |a Wanker, Erich |0 P:(DE-HGF)0 |b 7 | |
700 | 1 | |a Funke, Susanne Aileen |0 P:(DE-HGF)0 |b 8 | |
700 | 1 | |a Brener, Oleksandr |0 P:(DE-HGF)0 |b 9 | |
700 | 1 | |a Gremer, Lothar |0 P:(DE-Juel1)145165 |b 10 |u fzj | |
700 | 1 | |a Kutzsche, Janine |0 P:(DE-Juel1)159137 |b 11 |u fzj | |
700 | 1 | |a Willbold, Dieter |0 P:(DE-Juel1)132029 |b 12 |e Corresponding author |u fzj | |
773 | |a 10.1371/journal.pone.0153035 |g Vol. 11, no. 4, p. e0153035 - |0 PERI:(DE-600)2267670-3 |n 4 |p e0153035 - |t PLoS one |v 11 |y 2016 |x 1932-6203 | ||
856 | 4 | |u http://juser.fz-juelich.de/record/809114/files/Optimization%20of%20the%20All-D%20Peptide%20D3%20for%20A%CE%B2%20Oligomer%20Elimination_04_2016.pdf |y OpenAccess | |
856 | 4 | |u http://juser.fz-juelich.de/record/809114/files/Optimization%20of%20the%20All-D%20Peptide%20D3%20for%20A%CE%B2%20Oligomer%20Elimination_04_2016.pdf?subformat=pdfa |x pdfa |y OpenAccess | |
909 | C | O | |o oai:juser.fz-juelich.de:809114 |p openaire |p open_access |p OpenAPC |p driver |p VDB |p openCost |p dnbdelivery |
910 | 1 | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 1 |6 P:(DE-Juel1)162487 | |
910 | 1 | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 2 |6 P:(DE-Juel1)131709 | |
910 | 1 | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 3 |6 P:(DE-Juel1)130577 | |
910 | 1 | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 10 |6 P:(DE-Juel1)145165 | |
910 | 1 | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 11 |6 P:(DE-Juel1)159137 | |
910 | 1 | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 12 |6 P:(DE-Juel1)132029 | |
913 | 1 | |a DE-HGF |b Key Technologies |l BioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences |1 G:(DE-HGF)POF3-550 |0 G:(DE-HGF)POF3-553 |2 G:(DE-HGF)POF3-500 |v Physical Basis of Diseases |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 | |
913 | 1 | |a DE-HGF |b Key Technologies |l BioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences |1 G:(DE-HGF)POF3-550 |0 G:(DE-HGF)POF3-551 |2 G:(DE-HGF)POF3-500 |v Functional Macromolecules and Complexes |x 1 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 | |
914 | 1 | |y 2016 | |
915 | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS | ||
915 | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews | ||
915 | |a Creative Commons Attribution CC BY 4.0 |0 LIC:(DE-HGF)CCBY4 |2 HGFVOC | ||
915 | |a DBCoverage |0 StatID:(DE-HGF)1040 |2 StatID |b Zoological Record | ||
915 | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b PLOS ONE : 2014 | ||
915 | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ | ||
915 | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded | ||
915 | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection | ||
915 | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID | ||
915 | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID | ||
915 | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database | ||
915 | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline | ||
915 | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Thomson Reuters Master Journal List | ||
980 | 1 | |a FullTexts | |
980 | |a journal | ||
980 | |a VDB | ||
980 | |a I:(DE-Juel1)ICS-6-20110106 | ||
980 | |a I:(DE-Juel1)ICS-3-20110106 | ||
980 | |a UNRESTRICTED | ||
980 | |a APC | ||
536 | |a Functional Macromolecules and Complexes |0 G:(DE-HGF)POF3-551 |c POF3-551 |f POF III |x 1 | ||
536 | |a Physical Basis of Diseases |0 G:(DE-HGF)POF3-553 |c POF3-553 |f POF III |x 0 | ||
336 | |a ARTICLE |2 BibTeX | ||
336 | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1479892001_25248 |2 PUB:(DE-HGF) | ||
336 | |a Output Types/Journal article |2 DataCite | ||
336 | |a article |2 DRIVER | ||
336 | |a Nanopartikel unedler Metalle (Mg0, Al0, Gd0, Sm0) |0 0 |2 EndNote | ||
336 | |a JOURNAL_ARTICLE |2 ORCID | ||
981 | |a I:(DE-Juel1)IBI-7-20200312 | ||
920 | |l yes | ||
981 | |a I:(DE-Juel1)ICS-3-20110106 | ||
920 | |k Weiche Materie; ICS-3 |0 I:(DE-Juel1)ICS-3-20110106 |l Weiche Materie |x 1 | ||
981 | |a I:(DE-Juel1)IBI-4-20200312 | ||
920 | |k Strukturbiochemie; ICS-6 |0 I:(DE-Juel1)ICS-6-20110106 |l Strukturbiochemie |x 0 | ||
991 | |a Brener, Oleksandr |0 P:(DE-HGF)0 |b 9 | ||
991 | |a Funke, Susanne Aileen |0 P:(DE-HGF)0 |b 8 | ||
991 | |a Wanker, Erich |0 P:(DE-HGF)0 |b 7 | ||
991 | |a Willbold, Dieter |0 P:(DE-Juel1)132029 |b 12 |e Corresponding author |u fzj | ||
991 | |a Wiglenda, Thomas |0 P:(DE-HGF)0 |b 6 | ||
990 | |a Klein, Antonia Nicole |0 P:(DE-Juel1)145785 |b 0 | ||
991 | |a Kutzsche, Janine |0 P:(DE-Juel1)159137 |b 11 |u fzj | ||
991 | |a Boeddrich, Annett |0 P:(DE-HGF)0 |b 5 | ||
991 | |a Gremer, Lothar |0 P:(DE-Juel1)145165 |b 10 |u fzj | ||
991 | |a Bartnik, Dirk |0 P:(DE-Juel1)131991 |b 4 | ||
991 | |a Buitenhuis, Johan |0 P:(DE-Juel1)130577 |b 3 |u fzj | ||
991 | |a Tusche, Markus |0 P:(DE-Juel1)131709 |b 2 |u fzj | ||
991 | |a Ziehm, Tamar |0 P:(DE-Juel1)162487 |b 1 |u fzj |